SansRosa Pharmaceutical Development, Inc.

Topical agents to treat the redness associated with rosacea which was approved by the FDA in 2013. The company was acquired by CollaGenex, Inc. in 2005, which was later acquired by Galderma.

Exited Portfolio Company

www.galdermausa.com

Other Companies